Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Pain 16Cancer Pain 14Neoplasms 13Agnosia 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuralgia 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoma, Follicular 2Lymphoma 2Inflammation 2Head and Neck Neoplasms 2Bronchiolitis Obliterans Syndrome 2Acute Pain 2Waldenstrom Macroglobulinemia 1Urinary Tract Infections 1Trigger Finger Disorder 1Thrombocythemia, Essential 1Stomatitis 1Staphylococcal Infections 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Squamous Cell Carcinoma of Head and Neck 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sezary Syndrome 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1

Interventions

remimazolam 1Sugammadex 1Rocuronium 1Remifentanil 1Propofol 1Oxycodone 1Flumazenil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endobronchial Metastases × Oxycodone × Clear all
NCT05468671 2022-10-26

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Zhejiang Cancer Hospital

Phase 4 Completed
34 enrolled
GastrointestinalThoracic

Endobronchial Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡